Geography of Fracture Incidence in Postmenopausal Women with Osteoporosis Treated with Abaloparatide.
McClung, Michael R; Williams, Gregory C; Hattersley, Gary; Fitzpatrick, Lorraine A; Wang, Yamei; Miller, Paul D.
Calcif Tissue Int
; 102(6): 627-633, 2018 06.
Artigo em Inglês | MEDLINE | ID: mdl-29285549
Results of indirect and mixed treatment comparison of fracture efficacy for osteoporosis treatments: a meta-analysis.
European guidance for the diagnosis and management of osteoporosis in postmenopausal women.
Risk of imminent fracture following a previous fracture in a Swedish database study.
Obesity and fractures in postmenopausal women.
Prevention and rehabilitation of osteoporosis.
Long-term treatment strategies for postmenopausal osteoporosis.
The development of a personalized patient education tool for decision making for postmenopausal women with osteoporosis.
The impact of the new National Bone Health Alliance (NBHA) diagnostic criteria on the prevalence of osteoporosis in the USA.
Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial.
Possible FRAX-based intervention thresholds for a cohort of Chinese postmenopausal women.